| Income Statement |
| Operating Expenses | 5.68M |
|
| Research and Development Expense | 3.84M |
| Selling, General and Administrative Expense | 1.84M |
| Operating Income | -5.68M |
| Net Income | -6.39M |
| Net Income Common Stock | -6.39M |
| Net Income Common Stock (USD) | -6.39M |
| Consolidated Income | -6.39M |
| Earnings per Basic Share | -1.26 |
| Earnings per Basic Share (USD) | -1.26 |
| Earnings per Diluted Share | -1.26 |
| Earning Before Interest & Taxes (EBIT) | -6.39M |
| Earning Before Interest & Taxes (USD) | -6.39M |
| Weighted Average Shares | 2.29M |
| Weighted Average Shares Diluted | 2.29M |
| Balance Sheet |
| Cash and Equivalents | 6.94M |
| Cash and Equivalents (USD) | 6.94M |
| Current Assets | 7.54M |
| Property, Plant & Equipment Net | 7.23M |
| Total Assets | 14.83M |
| Debt Current | 393.00K |
| Total Debt | 393.00K |
| Current Liabilities | 1.87M |
| Total Liabilities | 1.87M |
| Accumulated Retained Earnings (Deficit) | -112.99M |
| Shareholders Equity | 12.96M |
| Shareholders Equity (USD) | 12.96M |
| Assets Non-Current | 7.29M |
| Total Debt (USD) | 393.00K |
| Trade and Non-Trade Payables | 992.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 843.00K |
| Net Cash Flow from Financing | 10.83M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.01M |
| Capital Expenditure | -1.00M |
| Issuance (Purchase) of Equity Shares | 10.83M |
| Net Cash Flow from Investing | -1.00M |
| Net Cash Flow from Operations | -5.81M |
| Share Based Compensation | -293.00K |